CTS-EVs originating from distinct cell types are implicated in MS pathology, encapsulating specific biomarkers, including myelin-derived proteins such as myelin basic protein (MBP), proteolipid protein (PLP), and myelin oligodendrocyte glycoprotein (MOG). The gene discussed is MBP; the disease is myeloid sarcoma.